All Research Papers Published In Neuromuscular Disorders

New
Research Article
10.1016/s0960-8966(26)00010-6

WMS Congress 2026 Hiroshima

Feb 1, 2026
Neuromuscular Disorders

New
Research Article
10.1016/s0960-8966(26)00009-x

WMS General Information

Feb 1, 2026
Neuromuscular Disorders

New
Research Article
10.1016/j.nmd.2026.106367

Spontaneous remission in statin-associated HMGCR-positive immune-mediated necrotizing myopathy after statin withdrawal

Feb 1, 2026
Neuromuscular Disorders
Agata A Mossakowski + 7 more

New
Research Article
10.1016/s0960-8966(26)00014-3

Editorial Board

Feb 1, 2026
Neuromuscular Disorders

New
Research Article
10.1016/j.nmd.2026.106366

Safety and Efficacy of Tamoxifen in Patients with Duchenne muscular dystrophy: Open Label Extension of TAMDMD Trial

Feb 1, 2026
Neuromuscular Disorders
Gaëtan Zwingli + 21 more

New
Research Article
10.1016/s0960-8966(26)00011-8

ENMC Themed Workshops

Feb 1, 2026
Neuromuscular Disorders

Research Article
10.1016/j.nmd.2026.106358

Editorial: The Importance of Patient Engagement in Scientific Research on Facioscapulohumeral Muscular Dystrophy

Jan 1, 2026
Neuromuscular Disorders
Nicol C Voermans

Research Article
10.1016/j.nmd.2026.106357

Correspondence on ‘Cardiac MRI for early detection of subclinical cardiac dysfunction in dysferlinopathy’ by Thomas et al.

Jan 1, 2026
Neuromuscular Disorders
Holly Borland + 2 more

Research Article
10.1016/j.nmd.2026.106354

Preemptive Immunotherapy for Fetal Acetylcholine Receptor Antibody Disorder (FARAD): From Recurrent Pregnancy Losses to a Healthy Infant - A case report

Jan 1, 2026
Neuromuscular Disorders
Stefan Verlohren + 8 more

Research Article
10.1016/j.nmd.2026.106360

Clinically important improvements in 6-minute walk distance and forced vital capacity in adults with late-onset Pompe disease switching from alglucosidase alfa to cipaglucosidase alfa plus miglustat in the PROPEL study

Jan 1, 2026
Neuromuscular Disorders
Stephan Wenninger + 9 more